NICE is recommending Janssen’s hepatitis C pill Incivo for funding on the NHS in England. The drug has bypassed the …

Vertex’s first-in-class treatment for cystic fibrosis Kalydeco has been approved by the FDA. The approval is a landmark in the …

The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …
NICE’s next round of drug appraisals is set to include two new hepatitis C drugs – Merck Sharpe and Dohme’s …
The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …
Telaprevir – currently being co-developed by Vertex, Johnson & Johnson and Mitsubishi Tanabe – will become part of a standard …

This year is expected to see new treatments for hepatitis C, multiple sclerosis and lupus among those that could reach …
Merck’s new oral hepatitis C drug boceprevir will receive fast track reviews from both the FDA and the EMA after …
A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …